# Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants

Study · id `cardio:ct-nct05340582` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05340582](<https://clinicaltrials.gov/study/NCT05340582>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05340582

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 310 participants.

## Technical summary

Registry record NCT05340582. Randomized; triple masking; primary purpose treatment. Start 2022-12-12 (actual); primary completion 2027-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 310 participants (planned count; ClinicalTrials.gov record NCT05340582, source copy `cardio:ctgov-nct05340582-2026-09-15`, retrieved 2026-10-26)
- Started: 2022-12-12 (actual) (ClinicalTrials.gov record NCT05340582, source copy `cardio:ctgov-nct05340582-2026-09-15`, retrieved 2026-10-26)
- Primary completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT05340582, source copy `cardio:ctgov-nct05340582-2026-09-15`, retrieved 2026-10-26)
- Completion: 2027-04 (anticipated) (ClinicalTrials.gov record NCT05340582, source copy `cardio:ctgov-nct05340582-2026-09-15`, retrieved 2026-10-26)
- Countries: Australia; Canada; Hong Kong SAR China; Ireland (ClinicalTrials.gov record NCT05340582, source copy `cardio:ctgov-nct05340582-2026-09-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05340582-2026-09-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
- Condition: Patent Ductus Arteriosus After Premature Birth
- Intervention (Drug): Acetaminophen Injection
- Intervention (Drug): Ibuprofen 20 mg/mL oral suspension or Ibuprofen lysine 10 mg/mL injection solution (Neoprofen)
- Intervention (Other): Sodium chloride 0.9% injection
- Lead sponsor: Mount Sinai Hospital, Canada
- Lead sponsor class: OTHER
- Collaborator: Sunnybrook Health Sciences Centre
- Collaborator class: OTHER
- Collaborator: McMaster Children's Hospital
- Collaborator class: OTHER
- Collaborator: The Rotunda Hospital
- Collaborator class: OTHER
- Collaborator: John Hunter Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: Royal Alexandra Hospital
- Collaborator class: OTHER
- Collaborator: Centre de Recheche du Centre Hospitalier Université Laval
- Collaborator class: OTHER
- Collaborator: Royal North Shore Hospital
- Collaborator class: OTHER
- Collaborator: Prince of Wales Hospital, Shatin, Hong Kong
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Mount Sinai Hospital, Canada (`cardio:org-mount-sinai-hospital-canada`)
- Registry lists this organization as a collaborator: Sunnybrook Health Sciences Centre (`cardio:org-sunnybrook-health-sciences-centre`)

## Provenance

Content hash: c8bdf71f5ed12c3aaf6e5d657ec83dd6fb65277425cb3b86ed9b58bb9ba404cb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
